Ishan Dyes (ISHANCH)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹48.17 |
| Market Cap | ₹131.64 Cr |
| P/E Ratio | 0 |
| ROCE | 4.04% |
| ROE | -5.78% |
| Dividend Yield | 0% |
| Profit Growth | -10,600% |
| Debt/Equity | 0.64 |
| Sales Growth | 89.8% |
| Promoter Holding | 37.48% |
| 52-Week Range | ₹41.5 — ₹83.37 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹54.34 |
Strengths
- Debt/Equity of 0.63 is moderate, providing some headroom despite losses.
- ROCE is positive at 4.04%, indicating some operating earnings before financing costs.
- Book value of ₹38.09 per share gives a tangible asset base.
- Latest quarter sales of ₹19 Cr show an existing revenue base.
Concerns
- ROE is -9.27% and the latest quarter had a net loss of ₹5 Cr, destroying shareholder value.
- Sales declined 11.8% and profit growth collapsed by -10,600%.
- Piotroski F-Score of 3/9 suggests weak financial health.
- No dividend, meaningless P/E, and a 64% premium to book value for a loss-making business.
AI Analysis
Charlie and I look for a business we understand, with durable economics and a manager who can put retaining earnings to work. Ishan Dyes operates in specialty chemicals, but the numbers tell me this is a troubled operation, not a compounder. In the latest quarter it generated ₹19 Cr of sales and lost ₹5 Cr. Trailing returns are poor: ROE is -9.27%, and ROCE is just 4.04%. A business that cannot earn its cost of capital is a poor allocator of capital. Sales are down 11.8%, and the profit collapse of -10,600% is really a fall from thin profits to clear losses. The P/E cannot be calculated; there is no E. The Piotroski score of 3/9 reinforces the weak financial health. What about assets? Book value is ₹38.09 per share, but the stock trades at ₹62.40, a 64% premium. I am not willing to pay a premium to book for a company that is shrinking and losing money. Debt to equity of 0.63 is not terrible, but losses will make that leverage heavier every year. There is no dividend to compensate while I wait. Promoter holding of 37.48% is not enough for me to infer strong insider alignment. In Graham's language, price is what you pay, value is what you get. Here, I see no value being created. The margin of safety lies in the price dropping well below book, or better, in a demonstrable turnaround: positive net profits, growing sales, and rising ROCE. Until I see those, this is a pass. The intelligent investor does not need to act on every stock.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer